fluorodeoxyglucose f18 has been researched along with Adenocarcinoma, Papillary in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 10 (47.62) | 29.6817 |
2010's | 8 (38.10) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Akan, S; Ediz, C; Terzi, NK; Yilmaz, O | 1 |
Han, SS; Kim, MK; Ko, A; Lee, ES; Park, HJ; Park, SB; Seok, JW | 1 |
Califano, I; Califano, L; Coduti, M; Otero, J; Quildrian, S; Rojas Bilbao, E | 1 |
Arizono, S; Doi, R; Haga, H; Hirokawa, Y; Isoda, H; Maetani, Y; Nakamoto, Y; Nitta, T; Shimada, K; Togashi, K; Yamashita, R | 1 |
Christodoulou, M; Letovanec, I; Prior, JO; Stupp, R | 1 |
Iizuka, K; Mizoguchi, K; Morita, S; Suzuki, M | 1 |
Altrinetti, V; Barbera, F; Bianchi, P; Biscaldi, E; Cabria, M; Foppiani, L; Morbelli, S; Piccardo, A; Villavecchia, G | 1 |
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Kuroki, M; Mizutani, Y; Nagamachi, S; Nakada, H; Nishii, R; Tamura, S; Uchino, N; Wakamatsu, H | 1 |
Li, H; Li, Y; Liang, S; Liu, J; Zhang, Y; Zhu, G | 1 |
Bissoli, S; Chierichetti, F; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
Baiocchi, GL; Bertagna, F; Calanducci, D; Gheza, F; Giubbini, R; Giulini, SM; Grazioli, L; Portolani, N | 1 |
Ambo, Y; Hirano, S; Katoh, C; Katoh, H; Kondo, S; Noji, T; Tamaki, N; Tanaka, E; Tsukamoto, E | 1 |
Higashi, T; Iida, Y; Ishimori, T; Iwata, M; Kasagi, K; Konishi, J; Matsumoto, K; Misaki, T; Nakamoto, Y; Saga, T | 1 |
Andoh, H; Asanuma, Y; Furuya, T; Hatazawa, J; Koyama, K; Sato, T; Shibata, S; Yoshioka, M | 1 |
Chang, TC; Chen, MY; Lai, CH; Ma, SY; Ng, KK; Wu, TI | 1 |
Biersack, HJ; Bucerius, J; Hortling, N; Jaeger, U; Joe, A; Meyka, S; Palmedo, H; Roedel, R; Strunk, H; Wardelmann, E; Wolff, M | 1 |
Dou, Y; Raja, S; Roscoe, KJ; Tronic, B | 1 |
Chung, YF; Goh, BK; Ng, DC; Selvarajan, S; Soo, KC | 1 |
Tuncel, M | 1 |
Bissoli, S; Chierichetti, F; Frison, L; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
Futoran, R; Glaspy, J; Hawkins, R; Hoh, C; Karlan, BY; Tse, N | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Adenocarcinoma, Papillary
Article | Year |
---|---|
Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube.
Topics: Adenocarcinoma, Papillary; Adult; Deoxyglucose; Fallopian Tube Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1993 |
3 trial(s) available for fluorodeoxyglucose f18 and Adenocarcinoma, Papillary
Article | Year |
---|---|
The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid c
Topics: Adenocarcinoma, Papillary; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2010 |
Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Confidence Intervals; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals | 2012 |
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sodium; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Treatment Outcome; Whole-Body Counting | 2004 |
17 other study(ies) available for fluorodeoxyglucose f18 and Adenocarcinoma, Papillary
Article | Year |
---|---|
Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male.
Topics: Adenocarcinoma, Papillary; Aged; BCG Vaccine; Carcinoembryonic Antigen; Carcinoma, Papillary; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Two cases of ovarian serous surface papillary borderline tumours with discordant 18F-FDG PET features.
Topics: Adenocarcinoma, Papillary; Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Young Adult | 2020 |
Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Topics: Adenocarcinoma, Papillary; Adult; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
F-18 fluorodeoxyglucose uptake in a solid pseudopapillary tumor of the pancreas mimicking malignancy.
Topics: Adenocarcinoma, Papillary; Adolescent; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Micropapillary pattern in lung adenocarcinoma: aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Phytotherapy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive (131)I whole body scan?
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Comparison of diagnostic and prognostic capabilities of ¹⁸F-FDG-PET/CT, ¹³¹I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2011 |
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques.
Topics: Adenocarcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multidetector Computed Tomography; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Intraductal oncocytic papillary neoplasm of the pancreas shows strong positivity on FDG-PET.
Topics: Adenocarcinoma, Papillary; Aged; Cholangiopancreatography, Endoscopic Retrograde; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatectomy; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2002 |
Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: a case report.
Topics: Adenocarcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgical Procedures, Operative; Surgical Sponges | 2005 |
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adenoma, Oxyphilic; Adult; Aged; Disease Management; Drug Resistance; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2006 |
Positron emission tomography with 2-deoxy-2-[18f] fluoro-D-glucose in the detection of malignancy in intraductal papillary mucinous neoplasms of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Correspondence: diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions.
Topics: Adenocarcinoma, Papillary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |